LQDA
NASDAQ
$77.08
Liquidia Corp (LQDA)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.
Sector:
Healthcare
Buy
Target: $74.25 (-3.67%)
Market Cap
$6.87B
Revenue 5Y CAGR
+137.36%
Profit Margin
39.8%
Forward P/E
20.12
Price Chart
Valuation
Market Cap$6.87B
P/E323.20
Forward P/E20.12
P/S24.00
P/B62.63
Profitability
Total Revenue (TTM)$288M
Gross Profit (TTM)$264M
EBITDA$47M
Profit Margin39.8%
Operating Margin46.3%
EPS$0.24
Financial Health
Free Cash Flow Yield0.60%
Growth & Risk
Revenue 5Y CAGR+137.36%
Beta (5Y)1.11
Sharpe Ratio2.76